林素芳 副研究員-論文

PUBLICATIONS

 (* indicates corresponding author)

  1. Chen YJ, Chen YL, Chang Y, Wu CC, Ko YC, Tsao SW, Chen JY, Lin SF*. (2017) Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes. J Virol 91 (15): e00736-17.
  2. Su MT, Wang YT, Chen YJ, Lin SF, Tsai CH, Chen MR. (2017) The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1. J Virol 91(9). pii: e02114-16.
  3. Lee CP, Liu GT, Kung HN, Liu PT, Liao YT, Chow LP, Chang LS, Chang YH, Chang CW, Shu WC, Angers A, Farina A, Lin SF, Tsai CH, Bouamr F, Chen MR. (2016) The Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-mediated Nuclear Envelope Modification for EBV Maturation. J Virol 90(20):8994-9007.
  4. Wu CC, Fang CY, Hsu HY, Chen YJ, Chou SP, Huang SY, Cheng YJ, Lin SF, Chang Y, Tsai CH, Chen JY (2016) Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes. Antiviral Res 132: 99-110.
  5. Chiu SH, Wu MC, Wu CC, Chen YC, Lin SF, Hsu JT, Yang CS, Tsai CH, Takada K, Chen MR, and Chen JY. (2014) Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle. J Virol 88:4962-75.
  6. Park R, El-Guindy A, Heston L, Lin SF, Yu KP, Nagy M, Borah S, Delecluse HJ, Steitz J, and Miller G. (2014) Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS ONE 9(4):e92593.
  7. Huang SY, Fang CY, Wu CC, Tsai CH, Lin SF, and Chen JY. (2013) Reactive Oxygen species mediate epstein-barr virus reactivation by N-methyl-N’-nitro-N-nitrosoguanidine. PLoS ONE 8(12):e84919.
  8. Wu CC, Chuang HY, Lin CY, Chen YJ, Tsai WH, Fang CY, Huang SY, Chuang FY, Lin SF, Chang Y, and Chen JY. (2013) Inhibition of epstein-barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane. Mol Carcinog 52:946-58.
  9. Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X, Lonigro RJ, Vats P, Wang R, Lin SF, Cheng AJ, Kunju LP, Siddiqui J, Tomlins SA, Wyngaard P, Sadis S, Roychowdhury S, Hussain M, Feng FY, Zalupski MM, Talpaz M, Pienta KJ, Rhodes DR, Robinson DR, and Chinnaiyan AM. (2013) Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov 3:636-47.
  10. Tsai WH, Chen YL, Chen HC, Cheng AJ, Chang KY, Chu PY, Hsiao JR, Chang JY, Lin SF*. (2012, Nov). Overexpression of Discoidin Domain Receptor 1 (DDR1) in oral squamous cell carcinoma. Eur J Cancer., 48(Suppl.6): 167.
  11. Chang YH, Lee CP, Su MT, Wang JT, Chen JY, Lin SF, Tsai CH, Hsieh MJ, Takada K, and Chen MR. (2012) Epstein-barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality. PLoS ONE 7(6): e39217.
  12. Tsai WH, Wang PW, Lin SY, Wu IL, Ko YC, Chen YL, Li M, and Lin SF*. (2012) Ser-634 and Ser-636 of Kaposi’s Sarcoma-Associated Herpesvirus RTA Are Involved in Transactivation and Are Potential CDK9 Phosphorylation Sites. Front Microbiol 3: 60.
  13. Ko YC, Tsai WH, Wang PW, Wu IL, Lin SY, Chen YL, Chen JY, and Lin SF*. (2012) Suppressive Regulation of Kaposi’s Sarcoma-Associated Herpesvirus RTA with O-GlcNAcylation. J Biomed Sci 19 (1):12.
  14. Huang SY, Hsieh MJ, Chen CY, Chen YJ, Chen JY, Chen MR, Tsai CH, Lin SF*, and Hsu TY. (2012) Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3σ arrests cells at G1/S transition by reducing cyclin E/CDK2 activity. J Gen Virol 93:139-49.
  15. Chen YJ, Tsai WH, Chen YL, Ko YC, Chou SP, Chen JY, and Lin SF*. (2011). Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi’s sarcoma-associated herpesvirus lytic reactivations in 293 cells. PLoS ONE 6(3): e17809.
  16. Chang PC, Fitzgerald LD, Hsia DA, Izumiya Y, Wu CY, Hsieh WP, Lin SF, Campbell M, Lam KS, Luciw PA, Tepper CG, and Kung HJ. (2011). Histone demethylase JMJD2A regulates KSHV replication and is targeted by a viral transcriptional factor. J Virol, 85:3283-93.
  17. Brown HJ, Peng L, Harada JN, Walker JR, Cole S, Lin SF, Zack JA, Chanda SK, and Sun, R. (2010). Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP response element-binding protein by gamma-herpesvirus replication and transcription activator. J Biol Chem 285:25139-25153.
  18. Tsai YH, Wu MF, Wu YH, Chang SJ, Lin SF, Sharp TV, and Wang HW. (2009). The M type K15 protein of Kaposi’s sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J Virol, 83:622-632.
  19. Chen YL, Chen YJ, Tsai WH, Ko YC, Chen JY, and Lin SF*. (2009). The Epstein-Barr Virus Replication and Transcription Activator, Rta/BRLF1, Induces Cellular Senescence In Epithelial Cells. Cell Cycle 8:58-65.
  20. Lee CP, Huang YH, Lin SF, Chang Y, Chang YH, Takada K, and Chen MR. (2008). Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82:11913-26.
  21. Liao W, Tang Y, Lin SF, Kung HJ, and Giam CZ. (2003). K-bZIP of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J Virol 77:3809-15.
  22. Izumiya Y, Lin SF, Ellison TJ, Levy AM, Mayeur GL, Izumiya C, and Kung HJ. (2003). Cell cycle regulation by Kaposi’s sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J Virol 77:9652-61.
  23. Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P, and Kung HJ. (2003). Kaposi’s sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 77:1441-51.
  24. Lin SF, Robinson DR, Oh J, Jung JU, Luciw PA, and Kung HJ. (2002). Identification of the bZIP and Rta homologues in the genome of rhesus monkey rhadinovirus. Virology 298:181-8.
  25. Parcells MS, Lin SF, Dienglewicz RL, Majerciak V, Robinson DR, Chen HC, Wu Z, Dubyak GR, Brunovskis P, Hunt HD, Lee LF, and Kung HJ. (2001). Marek’s disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75:5159-73.
  26. Robinson DR, Wu YM, and Lin SF. (2000). The protein tyrosine kinase family of the human genome. Oncogene 19:5548-57.
  27. Cinquina CC, Grogan E, Sun R, Lin SF, Beardsley GP, and Miller G. (2000). Dihydrofolate reductase from Kaposi’s sarcoma-associated herpesvirus. Virology 268:201-17.
  28. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, and Miller G. (1999). Kinetics of Kaposi’s sarcoma-associated herpesvirus gene expression. J Virol 73:2232-42.
  29. Liu JL, Lin SF, Xia L, Brunovskis P, Li D, Davidson I, Lee LF, and Kung HJ. (1999). MEQ and V-IL8: cellular genes in disguise? Acta Virol 43:94-101.
  30. Lin SF, Robinson DR, Miller G, and Kung HJ. (1999). Kaposi’s sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol 73:1909-17.
  31. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, and Miller G. (1998). A viral gene that activates lytic cycle expression of Kaposi’s sarcoma- associated herpesvirus. Proc Natl Acad Sci U S A 95:10866-71.
  32. Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, and Miller G. (1998). Serologic association of human herpesvirus eight with posttransplant Kaposi’s sarcoma in Saudi Arabia. Transplantation 65:583-5.
  33. Liu MT, Hsu TY, Lin SF, Seow SV, Liu MY, Chen JY, and Yang CS. (1998). Distinct regions of EBV DNase are required for nuclease and DNA binding activities. Virology 242:6-13.
  34. Angeloni A, Heston L, Uccini S, Sirianni MC, Cottoni F, Masala MV, Cerimele D, Lin SF, Sun R, Rigsby M, Faggioni A, and Miller G. (1998). High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi’s sarcoma from Sardinia. Journal of Infectious Diseases 177:1715-8.
  35. Sun R, Spain TA, Lin SF, and Miller G. (1997). Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA. J Virol 71:6136-43.
  36. Spain TA, Sun R, Gradzka M, Lin SF, Craft J, and Miller G. (1997). The transcriptional activator Sp1, a novel autoantigen. Arthritis & Rheumatism 40:1085-95.
  37. Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, and Miller G. (1997). Identification, expression, and immunogenicity of Kaposi’s sarcoma-associated herpesvirus-encoded small viral capsid antigen. Journal of Virology 71:3069-76.
  38. Sun R, Lin SF, Gradoville L, and Miller G. (1996). Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 93:11883-8.
  39. Lin SF, Hsu TY, Liu MY, Lin LS, Yang HL, Chen JY, and Yang CS. (1995). Characterization of Epstein-Barr virus DNase and its interaction with the major DNA binding protein. Virology 208:712-22.
  40. Sun R, Spain TA, Lin SF, and Miller G. (1994). Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. Proceedings of the National Academy of Sciences of the United States of America 91:8646-50.
  41. Lin SF, Lin SW, Hsu TY, Liu MY, Chen JY, and Yang CS. (1994). Functional analysis of the amino terminus of Epstein-Barr virus deoxyribonuclease. Virology 199:223-7.
  42. Liu MY, Lin SF, Hsu TY, Chen JY, and Yang CS. (1993). Analysis of Epstein-Barr virus BamHI F DNA fragment in nude mouse-passaged nasopharyngeal carcinoma tissues. Chung-Hua Min Kuo Wei Sheng Wu Chi Mien i Hsueh Tsa Chih – Chinese Journal of Microbiology & Immunology 26:68-77.
Share Button

Comments are closed.